Sitagliptin Add-On Improves Glycemic Measures After Metformin Dosage Increase in Type 2 Diabetes
The addition of sitagliptin to metformin therapy may be a useful strategy to avoid hyperglycemia during the process of metformin up-titration.
Hyperglycemia
Low Serum Vitamin D Levels May Be Associated With Higher Blood Glucose Levels
Low serum levels of 25-hydroxyvitamin D may be associated with elevated blood glucose levels, a major risk factor for type 2 diabetes.
Hyperglycemia During Pregnancy May Affect Childhood Glucose and Insulin Resistance in Offspring
Maternal glycemia during pregnancy may influence childhood glucose and insulin resistance regardless of BMI and family history of diabetes.
Hyperglycemia, Obesity, Hypertriglyceridemia Negatively Related to CAN in T2D
Hyperglycemia, obesity, and hypertriglyceridemia in type 2 diabetes are negatively related to indices of cardiovascular autonomic neuropathy.
Incretin-Based Therapies Not Associated With New-Onset Depression, Self-Harm in T2D
There was not a clinically relevant association between DPP-4 inhibitors or GLP-1 receptor agonists and depression or self-harm in type 2 diabetes.
Updated ADA, EASD Consensus Guidelines for Managing Hyperglycemia in T2D
Recommendations in the report highlight the importance of patient-centered decision making for glycemic management and improving diet and exercise for patients with T2D.
Individuals With Type 1 Diabetes See Improvement With Continuous Glucose Monitoring
Investigators seek to determine he effects of continuous glucose monitoring on daytime and nocturnal hypoglycemia in patients with type 1 diabetes.
Childhood Insulin Resistance Associated With Later Psychosis
The authors advised clinicians to carefully consider which antipsychotics they prescribe their patients with metabolic dysfunction, as some are known to be diabetogenic.
Clinicians May Be Overtreating Older Patients With Diabetes
Future research should further investigate the process and influences on clinician decision-making regarding individualizing glucose targets for high-risk geriatric patients, including the influence of training and practice environment.
Pattern of Placebo Response in Oral Antihyperglycemic Agent Drug Trials
Placebo-treated patients with diabetes commonly experienced a reduction in HbA1c, more markedly in augmented vs exclusively placebo-controlled treatment arms.
Next post in Type 2 Diabetes
